The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide

R.W. Rapkins, F. Wang, H.T.N. Nguyen, T.F. Cloughesy, A. Lai, W. Ha, Anna Nowak, M.P. Hitchins, K.L. Mcdonald

Research output: Contribution to journalArticle

37 Citations (Scopus)
Original languageEnglish
Pages (from-to)1589-1598
JournalNeuro-Oncology
Volume17
Issue number12
DOIs
Publication statusPublished - 2015

Cite this

Rapkins, R. W., Wang, F., Nguyen, H. T. N., Cloughesy, T. F., Lai, A., Ha, W., Nowak, A., Hitchins, M. P., & Mcdonald, K. L. (2015). The MGMT promoter SNP rs16906252 is a risk factor for MGMT methylation in glioblastoma and is predictive of response to temozolomide. Neuro-Oncology, 17(12), 1589-1598. https://doi.org/10.1093/neuonc/nov064